No Detail Found!

Assessment of Carcino-Embryonic Antigen (CEA) in patients with Colorectal Carcinoma (CRC).

Author(s)
Junaid Mahmood Alam Department of Biochemistry and Chemical Pathology, Liaquat National Hospital, Karachi-74800, Pakistan
Mohd Azhar Imam Department of Biochemistry and Chemical Pathology, Liaquat National Hospital, Karachi-74800, Pakistan
Aijaz Ahmed Department of Biochemistry and Chemical Pathology, Liaquat National Hospital, Karachi-74800, Pakistan
Ishrat Sultana Department of Biochemistry and Chemical Pathology, Liaquat National Hospital, Karachi-74800, Pakistan
Syed Riaz Mahmood Baqai Medical University, Karachi, Pakistan
Sarah Sughra Asghar Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan
Abstract
The CEA molecule is an onco-development human tumor marker and bears the cluster differentiation designation of CD66e. It has a molecular weight of 180 kDa. CEA is one of the significant entities to diagnose and monitor solid tumor and the response to therapy, in GIT cancers, especially CRC. Due to substantial clinical importance of CEA for diagnosis, prognosis and treatment, a study was carried out to assess its levels in patients suspected off or diagnosed with GIT cancers, with special reference to colorectal carcinoma (CRC). A total 86 patients, 70 (81.39%) males and 16 (18.60%) females, were included in the study with age range of 36 to 81 years. Out of 70 males, 23 (32.80%) have malignant conditions and exhibited elevated levels of CEA (66 ng/ml to 230 ng/ml; mean = 189+18 ng/ml), whereas 47 have non-malignant complications with normal or non-significant (> 10 ng/ml but
Publication Details
Page(s) 13-18
DOI DOI not available
Published Journal: Journal of Baqai Medical University, Volume: 7, Issue: 1, Year: 2004

Request the full text from PASTIC

0

Citations

0

Downloads

88

Views